HCV Advocate Email Alert

[Guest guest]

HCV Advocate Email Alert

Hello,

The following items have been recently uploaded to

<http://www.hcvadvocate.org/> www.hcvadvocate.org and

<http://www.hbvadvocate.org/> www.hbvadvocate.org:

* Glossary of Medical Terms - updated

<http://www.hcvadvocate.org/library/glossary.asp>

http://www.hcvadvocate.org/library/glossary.asp

* HCV Drug Pipeline - updated

<http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html>

http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html

* Medicare Advantage, by Jacques Chambers, CLU :

<http://www.hcvadvocate.org/hepatitis/hepC/Medicare%20Advantage.html>

http://www.hcvadvocate.org/hepatitis/hepC/Medicare%20Advantage.html

* HBV: Which Antiviral to Use First , by Kukka

<http://www.hbvadvocate.org/hepatitis/hepB/antiviral_first.html>

http://www.hbvadvocate.org/hepatitis/hepB/antiviral_first.html

* Weekly News Review : Week Ending December 9th, 2006

<http://www.hcvadvocate.org/news/newsRev/2006/NewsRev-182.html>

http://www.hcvadvocate.org/news/newsRev/2006/NewsRev-182.html

Thanks!

Alan Franciscus

Executive Director, Hepatitis C Support Project

Editor-in-Chief, HCV Advocate

Unsubscribe Information:

[Guest guest]

HCV Advocate Email Alert

Hello,

The following items have been posted to <http://www.hcvadvocate.org/>

www.hcvadvocate.org and <http://www.hbvadvocate.org/>

www.hbvadvocate.org - All the items listed below are on our front page:

*** HBV Journal Review, March 2007

***Hepatitis C Journal Review: March 5th, 2007

by Liz Highleyman

http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.5.html

***When Disability Insurance Says You're No Longer Disabled

by Jacques Chambers, CLU

<http://www.hcvadvocate.org/hepatitis/hepC/LTD%20No%20Longer%20Disabled_

2007.htm>

http://www.hcvadvocate.org/hepatitis/hepC/LTD%20No%20Longer%20Disabled_2

007.htm

***Weekly News Review: Week Ending March 10th, 2007

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-195.html>

http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-195.html

***Registration: Train the Trainer: Cleveland , March 30th - Reg

Deadline: March 9th

<http://www.hcvadvocate.org/community/community_pdf/Cleveland_2007.pdf>

http://www.hcvadvocate.org/community/community_pdf/Cleveland_2007.pdf

***Registration An Advocate's Perspective on New Drugs in the Pipeline A

Community Dinner and Forum for People with Hepatitis C -- Denver , April

17th

<http://www.hcvadvocate.org/community/community_pdf/April_17_Community_D

inner.pdf>

http://www.hcvadvocate.org/community/community_pdf/April_17_Community_Di

nner.pdf

Thanks!

Alan Franciscus

Executive Director, Hepatitis C Support Project

Editor-in-Chief, HCV Advocate

Unsubscribe Information:

[Guest guest]

HCV Advocate Email Alert

Hello,

The following items have been posted to <http://www.hcvadvocate.org/>

www.hcvadvocate.org and <http://www.hbvadvocate.org/>

www.hbvadvocate.org - All the items listed below are on our front page:

*** HBV Journal Review, March 2007

***Hepatitis C Journal Review: March 5th, 2007

by Liz Highleyman

http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.5.html

***When Disability Insurance Says You're No Longer Disabled

by Jacques Chambers, CLU

<http://www.hcvadvocate.org/hepatitis/hepC/LTD%20No%20Longer%20Disabled_

2007.htm>

http://www.hcvadvocate.org/hepatitis/hepC/LTD%20No%20Longer%20Disabled_2

007.htm

***Weekly News Review: Week Ending March 10th, 2007

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-195.html>

http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-195.html

***Registration: Train the Trainer: Cleveland , March 30th - Reg

Deadline: March 9th

<http://www.hcvadvocate.org/community/community_pdf/Cleveland_2007.pdf>

http://www.hcvadvocate.org/community/community_pdf/Cleveland_2007.pdf

***Registration An Advocate's Perspective on New Drugs in the Pipeline A

Community Dinner and Forum for People with Hepatitis C -- Denver , April

17th

<http://www.hcvadvocate.org/community/community_pdf/April_17_Community_D

inner.pdf>

http://www.hcvadvocate.org/community/community_pdf/April_17_Community_Di

nner.pdf

Thanks!

Alan Franciscus

Executive Director, Hepatitis C Support Project

Editor-in-Chief, HCV Advocate

Unsubscribe Information:

[Guest guest]

HCV Advocate Email Alert

<http://www.hcvadvocate.org/images/eblast_logo.jpg>

Hello,

The following items have been posted to www.hcvadvocate.org

<http://www.hcvadvocate.org/> and www.hbvadvocate.org

<http://www.hbvadvocate.org/>

*** <http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html> Hepatitis

C Treatments in Current Clinical Development: Updated December 1st, 2007

An overview of the latest drugs being developed for the treatment of

Hepatitis C

*** <http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html>

December 2007 HCV Advocate

Download English printable version

Download Spanish printable version

. The

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#1>

Big 3 at AASLD: Drugs in Development

Alan Franciscus, Editor-in-Chief

. HIV/HCV

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#2>

Coinfection Updates from AASLD 2007

Liz Highleyman

. HealthWise:

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#3>

Supporting your Immune System

Lucinda K. Porter, RN, CCRC

. Disability

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#4> &

Benefits: SSI and SSDI: Open Enrollment for Employer Plans and Medicare

Jacques Chambers, CLU

*** <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html> HCV

ADVOCATE WEEKLY NEWS REVIEW:

A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

Week Ending: December 1st , 2007

To download pdf version click here

<http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2007/NewsRe

v-233.pdf>

This Issue:

* Hepatitis

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Hepatiti

s_scare_stokes> scare stokes concerns about needles, syringes

* Family

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Family_s

truggles_against> struggles against foreclosure

* Artificial

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Artifici

al_liver_offers> liver offers sufferers new hope

* Maxygen

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Maxygen_

ends_hepatitis> ends hepatitis drug development

* Peregrine

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Peregrin

e_Announces_Addition> Announces Addition of The s Hopkins Hospital

as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV

* Mexican

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Mexican_

Americans_Carrying> Americans Carrying Haplotype H6 Of The CYP2E1 Gene

Have A Greater Risk Of Alcoholism

* 10

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_10_top_t

ips> top tips - hepatitis C

* Inovio

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Inovio_B

iomedical_Partner> Biomedical Partner Tripep Treats First Subject in

Phase I/II Study of Novel Hepatitis C DNA Vaccine

* Drug

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Drug_boo

sts_platelets> boosts platelets in hepatitis C patients

* Commissioner

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Commissi

oner_Vows_Changes> Vows Changes After Needle Scare

* Alta.

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Alta._ho

spital_patients> hospital patients test positive for Hep B, C

* Boat's

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Boat's_B

attle> Battle

* HepaGamB

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_HepaGamB

_In-Home_Aftercare> In-Home Aftercare Access Program for Liver

Transplant Patients Launched By Apotex and Centric Health Resources

* Graft

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Graft_Si

ze_May> Size May Affect Thrombocytopenia After Liver Transplant

* Long-Term

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Long-Ter

m_Liver_Transplant> Liver Transplant Better in UK Than in US

* Ministry

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Ministry

_accepts_blame> accepts blame for silence over hepatitis infection

***HEPATITIS

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html> JOURNAL

REVIEW:

A Bi-Monthly Publication of the Hepatitis Support Project

November 25, 2007

Volume 4, Issue 21

Liz Highleyman

To download pdf version click here

In This Issue:

Hepatitis C

.. Prolonged

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#1>

Interferon-based Therapy

.. Merimepodib

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#2> for

Prior Nonresponders

.. Treating

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#3> Patients

with Cirrhosis

.. Acute <http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#4>

Hepatitis C

.. HCV Sexual

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#5>

Transmission

Thanks!

Alan Franciscus

Executive Director, Hepatitis C Support Project

Editor-in-Chief, HCV Advocate

Unsubscribe Information:

[Guest guest]

HCV Advocate Email Alert

<http://www.hcvadvocate.org/images/eblast_logo.jpg>

Hello,

The following items have been posted to www.hcvadvocate.org

<http://www.hcvadvocate.org/> and www.hbvadvocate.org

<http://www.hbvadvocate.org/>

*** <http://www.hcvadvocate.org/hepatitis/hepC/HCVDrugs.html> Hepatitis

C Treatments in Current Clinical Development: Updated December 1st, 2007

An overview of the latest drugs being developed for the treatment of

Hepatitis C

*** <http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html>

December 2007 HCV Advocate

Download English printable version

Download Spanish printable version

. The

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#1>

Big 3 at AASLD: Drugs in Development

Alan Franciscus, Editor-in-Chief

. HIV/HCV

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#2>

Coinfection Updates from AASLD 2007

Liz Highleyman

. HealthWise:

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#3>

Supporting your Immune System

Lucinda K. Porter, RN, CCRC

. Disability

<http://www.hcvadvocate.org/news/newsLetter/2007/advocate1207.html#4> &

Benefits: SSI and SSDI: Open Enrollment for Employer Plans and Medicare

Jacques Chambers, CLU

*** <http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html> HCV

ADVOCATE WEEKLY NEWS REVIEW:

A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

Week Ending: December 1st , 2007

To download pdf version click here

<http://www.hcvadvocate.org/news/NewsUpdates_pdf/News_Review_2007/NewsRe

v-233.pdf>

This Issue:

* Hepatitis

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Hepatiti

s_scare_stokes> scare stokes concerns about needles, syringes

* Family

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Family_s

truggles_against> struggles against foreclosure

* Artificial

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Artifici

al_liver_offers> liver offers sufferers new hope

* Maxygen

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Maxygen_

ends_hepatitis> ends hepatitis drug development

* Peregrine

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Peregrin

e_Announces_Addition> Announces Addition of The s Hopkins Hospital

as Study Site for Bavituximab Trial in HCV Patients Co-Infected With HIV

* Mexican

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Mexican_

Americans_Carrying> Americans Carrying Haplotype H6 Of The CYP2E1 Gene

Have A Greater Risk Of Alcoholism

* 10

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_10_top_t

ips> top tips - hepatitis C

* Inovio

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Inovio_B

iomedical_Partner> Biomedical Partner Tripep Treats First Subject in

Phase I/II Study of Novel Hepatitis C DNA Vaccine

* Drug

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Drug_boo

sts_platelets> boosts platelets in hepatitis C patients

* Commissioner

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Commissi

oner_Vows_Changes> Vows Changes After Needle Scare

* Alta.

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Alta._ho

spital_patients> hospital patients test positive for Hep B, C

* Boat's

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Boat's_B

attle> Battle

* HepaGamB

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_HepaGamB

_In-Home_Aftercare> In-Home Aftercare Access Program for Liver

Transplant Patients Launched By Apotex and Centric Health Resources

* Graft

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Graft_Si

ze_May> Size May Affect Thrombocytopenia After Liver Transplant

* Long-Term

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Long-Ter

m_Liver_Transplant> Liver Transplant Better in UK Than in US

* Ministry

<http://www.hcvadvocate.org/news/newsRev/2007/NewsRev-233.html#_Ministry

_accepts_blame> accepts blame for silence over hepatitis infection

***HEPATITIS

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html> JOURNAL

REVIEW:

A Bi-Monthly Publication of the Hepatitis Support Project

November 25, 2007

Volume 4, Issue 21

Liz Highleyman

To download pdf version click here

In This Issue:

Hepatitis C

.. Prolonged

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#1>

Interferon-based Therapy

.. Merimepodib

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#2> for

Prior Nonresponders

.. Treating

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#3> Patients

with Cirrhosis

.. Acute <http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#4>

Hepatitis C

.. HCV Sexual

<http://www.hcvadvocate.org/news/newsRev/2007/HJR-4.21.html#5>

Transmission

Thanks!

Alan Franciscus

Executive Director, Hepatitis C Support Project

Editor-in-Chief, HCV Advocate

Unsubscribe Information:

[Guest guest]

> Date: Sun, 17 Aug 2008 21:33:42 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> * Spanish Easy Facts Updated and Designed

> Be sure to check out our updated and redesigned Easy Facts in Spanish (Datos

Sencillos)

>

>

>

> * HEPATITIS JOURNAL REVIEW: August 15, 2008 Volume 5, Issue 8

> by Liz Highleyman

>

> To download pdf version click here

>

> In This Issue:

>

> Antiviral Treatment for Cirrhotic Patients

>

> EPO Safe for Managing Anemia

>

> Obesity and Diabetes Predict Liver Disease Progression

>

> Sorafenib for Liver Cancer

>

> HIV/HCV Coinfection Does Not Impair CD4 Cell Recovery

>

> Low Risk of Liver Mitochondrial Toxicity on HAART

>

>

>

> *HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: August 16 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> Genes might be key to hepatitis C

> Health worker wages personal and professional war on hepatitis

> Gilead wins OK to promote drug for hepatitis B

> GPs on the spot over blood tests

> Hepatitis C coinfection may increase the risk of heart attacks and strokes in

people with HIV

> Cara Mastrey to Visit KNAC.COM Today to Discuss Tawn Mastrey Hepatitis C Aware

Project

> Nano Vaccine For Hepatitis B Shows Promise For Third World - Nanoemulsion

Could Save More Lives By Removing Current Vaccines' Drawbacks

> Hepatitis B virus genotype and mutations affect risk of cancer

> Court Upholds Compensation Cut-off For NHS Hepatitis Victim

> Older Donor Grafts Suitable for Liver Transplant Recipients With Hepatitis C

Virus

> Waiting times double for transplants

> Music helps Kenny Neal get over the blues

> Spreading the word on Hepatitis C

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Mon, 22 Sep 2008 14:29:09 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** ACTION ALERT: Urge Obama and McCain to Include Hepatitis C in Campaign

Message

> Click Here

>

> *** Registration: Hepatitis C Training Workshop, Glen , Virginia,

November 10, 2008. Click here for more information

>

>

> *** Hepatitis Journal Review: Vol 5 no.9 (September, 2008), by Liz Highleyman,

> In This Issue:

>

> Shorter Therapy for HCV Genotypes 1/4

>

> Directly Targeted Therapy

>

> Resistance to HCV Protease Inhibitors

>

> Albumin Interferon

>

> Fibrosis Progression

>

> HCV Neutralizing Antibodies in Coinfected Patients

>

>

>

> *** Updated HSCP Publications

>

> After HCV Treatment: An HCSP Guide

>

> HCV Negative: A Guide for Healthy Living without HCV

>

> Finding a Hepatitis C Support Group

>

>

> *** Hojas Informativas actualizadas y reajustadas (HSCP Factsheets in Spanish)

>

> Hierbas medicinales y hepatitis C - 2ª edición (Herbs and Hepatitis C)

> El paracetamol y el hígado (Acetaminophen and Your Liver)

> ¿Qué es la cirrosis? (What is Cirrhosis?)

> ¿Qué es la fibrosis? (What is Fibrosis?)

> Esteatosis (Steatosis)

>

>

>

> *** New HBV CME Course Launched! Click here for more info

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: September 20 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> Hepatitis sufferers, Mitsubishi Tanabe to reach accord

> Recent findings from Army highlight research in hepatitis C virus

> Researchers Invigorate " Exhausted " Immune Cells: Findings Support New

Therapies for HIV, Hepatitis, Cancer

> Groups offering Hepatitis B screenings

> Stanley Greene: Photographing Illness While Confronting His Own

> Supervisors, go with grand jury on needle swap

> Family Hepatitis Service: Crossing the Hospital and Community Divide

> Patient Contracts Hepatitis-C from Dialysis Center

> Blood agency honours retired judge

> Jazz Pharmaceuticals, Inc. Announces Final Patient Has Completed Phase III

Clinical Trial of Sodium Oxybate to Treat Fibromyalgia

> Hep C drug developer lays off all of its staff

> Three Rivers Pharmaceuticals®, LLC Obtains Additional Commercial Rights to

Infergen® from Amgen Inc.

> Aethlon Medical Reports Promising Treatment Results In Hepatitis-C Infected

Patients

> Hyponatremia May Predict Mortality Among Patients Awaiting Liver Transplant

> Blacks have higher mortality after liver surgery

> Familial Sources, Genetic Predisposition Seen in Clustering of Hepatitis C

> Supervisors nix needle exchange

> The prevalence of hepatitis B virus infection in inflammatory bowel disease

patients

> New guidance for hepatitis B infection

> Exercise reduces fat in livers of diabetics: study

> Cocoa woman starts hepatitis C support group

> New Mexico in Focus " Takes an In-Depth Look at Hepatitis C

> Cole hospitalized due to hepatitis C

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Tue, 30 Sep 2008 21:22:47 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** HCV Advocate Monthly Newsletter, October 2008

>

> In This Issue:

>

> HCV Drug Pipeline Update

> Alan Franciscus, Editor-in-Chief

>

> Hearing Loss and Hepatitis C

> C.D. Mazoff, PhD, Managing Editor

>

> HealthWise: Hepatitis C and Liver Transplantation

> Lucinda Porter, RN

>

> Vaccine to Prevent HCV Remains Elusive

> Liz Highleyman

>

> Short Takes on HCV, Diabetes and Diet

> Alan Franciscus, Editor-in-Chief

>

> A Simple Way to Prevent Disease!

> Alan Franciscus, Editor-in-Chief

>

>

>

> ***Medical Writers' Circle:

> Increasing the Chance of Receiving Liver Transplantation by Multiple Listing,

> by Lorenzo Rossaro, MD

>

>

>

> *** HBV Journal Review, October 2008, by Kukka

>

>

>

> *** COBRA - What Happens When It Ends, by Jacques Chambers, CLU

>

>

>

> *** Top Ten Downloads of September 2008

> Check out this link to see what everyone is reading

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: September 27 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> UCSF Celebrates 45th Anniversary of Transplant Service

> Life or liberty?

> Author gives view from addiction to redemption

> SciClone Provides Promising Results From Its Phase 2A Clinical Trial Using

SCV-07 as a Monotherapy in Patients With Chronic Hepatitis C Infection

> Infection with hepatitis C virus (HCV) may suppress co-infection with

hepatitis B virus (HBV) during acute or chronic HBV infection

> CDC recommends Asian, African immigrants be tested for hepatitis B

> Hepatitis C sufferers miss out on treatment

> China warns of tougher punishment for bad blood

> Phase IIa data on TMC435350 in patients with hepatitis C to be presented at

AASLD

> Anadys Pharmaceuticals Announces Successful Outcome of ANA598 Healthy

Volunteer Study and Finalization of Study Design for Phase Ib Trial in HCV

Patients

> Telaprevir Presentations at the 59th AASLD Meeting to Feature SVR Data in

Treatment-Naïve and Treatment-Failure Genotype 1 HCV Patients, and Clinical

Data Exploring Twice-Daily Dosing Regimens

> What Is The Energy Consuming Style In Chronic Severe Hepatitis B Patient

Normality?

> How to select anti-hepatitis B virus agents for drug-resistance patients?

> GlobeImmune Announces Late-Breaker Presentation of Interim Efficacy and Safety

Data for GI-5005 at AASLD 2008 Meeting

> Duke NCRC researchers studying

> Successful construction of eukaryotic plasmids containing HBV C genotype

> Presidential Candidates Present Their Healthcare Reform Plans in NEJM

> Health spending may have to slow as economy stalls

> Cancer Clinic Causes Worst Hepatitis Outbreak in US History

> Court sides with firefighter in city suit

> REVIEW: Will Self, Southport Arts Centre

> Injection missteps case ends in settlement deal

> Novel Therapy For Bleeding Gastric Varices

> InterMune Previews a Coming Attraction

> 'Hepatitis B shot doesn't raise multiple sclerosis risk'

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Wed, 15 Oct 2008 15:34:36 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis Journal Review , October 2008, by Liz Highleyman

>

> In This Issue

>

> Long-term HCV Eradication

>

> SVR Does Not Always Prevent HCC

>

> Warfarin May Slow Fibrosis Progression

>

> HCV Genotype 6

>

> Kidney Disease in People with HCV and HIV/HCV Coinfection

>

> Ribavirin Doses in Coinfected Patients

>

>

>

> *** Open Enrollment for Employer Plans and Medicare - 2008, by Jacques

Chambers, CLU

>

> The time of year is approaching when many employers provide an Open Enrollment

Period for their employees allowing them to make changes in their employee

benefits choices. Also, from November 15 through December 31 Medicare

beneficiaries are able to make changes in their coverages as well. Employee

benefits changes are covered below with Medicare changes after that.

>

>

>

> *** Registration for Upcoming HCSP Training Workshops

>

> Virginia - Nov 10 - Click here for more info

>

> South Carolina - Nov 13 - Click here for more info

>

>

>

> *** HCV Drug Pipleline: Updated October 15, 2008

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: October 11 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> HIV, hepatitis tests urged for tattoo parlour clients

> Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron®

Commercial Rights

> Urgent need for action to tackle hepatitis C

> Vitamin D Deficiency Prevalent in Patients with Chronic Liver Disease

> Antiretroviral therapy does not fully reverse impact of HIV on hepatitis

C-related cirrhosis

> Experts Unite in New York; Discuss Hepatitis C and New Treatment Developments

> Former Hartford Mayor Recovering After Surgery

> Compass in calls for industry-wide Hep C guidelines

> Serum Ribavirin Level Impacts Outcome in HCV-HIV Coinfection

> FDA Safety Changes: Baraclude

> Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV

Polymerase Inhibitor at the 15th International Symposium on Hepatitis C Virus

and Related Viruses

> Longing For A Liver

> Alcohol not only cause of cirrhosis

> Doctor blamed in case of infected IHC carer

> Viral Hepatitis C support group to begin meeting

> Ailing deputy withdraws grievance after county approves leave, insurance

> Cancer common after liver transplantation

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Wed, 15 Oct 2008 15:34:36 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis Journal Review , October 2008, by Liz Highleyman

>

> In This Issue

>

> Long-term HCV Eradication

>

> SVR Does Not Always Prevent HCC

>

> Warfarin May Slow Fibrosis Progression

>

> HCV Genotype 6

>

> Kidney Disease in People with HCV and HIV/HCV Coinfection

>

> Ribavirin Doses in Coinfected Patients

>

>

>

> *** Open Enrollment for Employer Plans and Medicare - 2008, by Jacques

Chambers, CLU

>

> The time of year is approaching when many employers provide an Open Enrollment

Period for their employees allowing them to make changes in their employee

benefits choices. Also, from November 15 through December 31 Medicare

beneficiaries are able to make changes in their coverages as well. Employee

benefits changes are covered below with Medicare changes after that.

>

>

>

> *** Registration for Upcoming HCSP Training Workshops

>

> Virginia - Nov 10 - Click here for more info

>

> South Carolina - Nov 13 - Click here for more info

>

>

>

> *** HCV Drug Pipleline: Updated October 15, 2008

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: October 11 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> HIV, hepatitis tests urged for tattoo parlour clients

> Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron®

Commercial Rights

> Urgent need for action to tackle hepatitis C

> Vitamin D Deficiency Prevalent in Patients with Chronic Liver Disease

> Antiretroviral therapy does not fully reverse impact of HIV on hepatitis

C-related cirrhosis

> Experts Unite in New York; Discuss Hepatitis C and New Treatment Developments

> Former Hartford Mayor Recovering After Surgery

> Compass in calls for industry-wide Hep C guidelines

> Serum Ribavirin Level Impacts Outcome in HCV-HIV Coinfection

> FDA Safety Changes: Baraclude

> Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV

Polymerase Inhibitor at the 15th International Symposium on Hepatitis C Virus

and Related Viruses

> Longing For A Liver

> Alcohol not only cause of cirrhosis

> Doctor blamed in case of infected IHC carer

> Viral Hepatitis C support group to begin meeting

> Ailing deputy withdraws grievance after county approves leave, insurance

> Cancer common after liver transplantation

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Wed, 15 Oct 2008 15:34:36 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis Journal Review , October 2008, by Liz Highleyman

>

> In This Issue

>

> Long-term HCV Eradication

>

> SVR Does Not Always Prevent HCC

>

> Warfarin May Slow Fibrosis Progression

>

> HCV Genotype 6

>

> Kidney Disease in People with HCV and HIV/HCV Coinfection

>

> Ribavirin Doses in Coinfected Patients

>

>

>

> *** Open Enrollment for Employer Plans and Medicare - 2008, by Jacques

Chambers, CLU

>

> The time of year is approaching when many employers provide an Open Enrollment

Period for their employees allowing them to make changes in their employee

benefits choices. Also, from November 15 through December 31 Medicare

beneficiaries are able to make changes in their coverages as well. Employee

benefits changes are covered below with Medicare changes after that.

>

>

>

> *** Registration for Upcoming HCSP Training Workshops

>

> Virginia - Nov 10 - Click here for more info

>

> South Carolina - Nov 13 - Click here for more info

>

>

>

> *** HCV Drug Pipleline: Updated October 15, 2008

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: October 11 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> HIV, hepatitis tests urged for tattoo parlour clients

> Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron®

Commercial Rights

> Urgent need for action to tackle hepatitis C

> Vitamin D Deficiency Prevalent in Patients with Chronic Liver Disease

> Antiretroviral therapy does not fully reverse impact of HIV on hepatitis

C-related cirrhosis

> Experts Unite in New York; Discuss Hepatitis C and New Treatment Developments

> Former Hartford Mayor Recovering After Surgery

> Compass in calls for industry-wide Hep C guidelines

> Serum Ribavirin Level Impacts Outcome in HCV-HIV Coinfection

> FDA Safety Changes: Baraclude

> Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV

Polymerase Inhibitor at the 15th International Symposium on Hepatitis C Virus

and Related Viruses

> Longing For A Liver

> Alcohol not only cause of cirrhosis

> Doctor blamed in case of infected IHC carer

> Viral Hepatitis C support group to begin meeting

> Ailing deputy withdraws grievance after county approves leave, insurance

> Cancer common after liver transplantation

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Wed, 15 Oct 2008 15:34:36 -0400

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis Journal Review , October 2008, by Liz Highleyman

>

> In This Issue

>

> Long-term HCV Eradication

>

> SVR Does Not Always Prevent HCC

>

> Warfarin May Slow Fibrosis Progression

>

> HCV Genotype 6

>

> Kidney Disease in People with HCV and HIV/HCV Coinfection

>

> Ribavirin Doses in Coinfected Patients

>

>

>

> *** Open Enrollment for Employer Plans and Medicare - 2008, by Jacques

Chambers, CLU

>

> The time of year is approaching when many employers provide an Open Enrollment

Period for their employees allowing them to make changes in their employee

benefits choices. Also, from November 15 through December 31 Medicare

beneficiaries are able to make changes in their coverages as well. Employee

benefits changes are covered below with Medicare changes after that.

>

>

>

> *** Registration for Upcoming HCSP Training Workshops

>

> Virginia - Nov 10 - Click here for more info

>

> South Carolina - Nov 13 - Click here for more info

>

>

>

> *** HCV Drug Pipleline: Updated October 15, 2008

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: October 11 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> HIV, hepatitis tests urged for tattoo parlour clients

> Biolex Therapeutics Enters Into Agreement to Acquire Full Locteron®

Commercial Rights

> Urgent need for action to tackle hepatitis C

> Vitamin D Deficiency Prevalent in Patients with Chronic Liver Disease

> Antiretroviral therapy does not fully reverse impact of HIV on hepatitis

C-related cirrhosis

> Experts Unite in New York; Discuss Hepatitis C and New Treatment Developments

> Former Hartford Mayor Recovering After Surgery

> Compass in calls for industry-wide Hep C guidelines

> Serum Ribavirin Level Impacts Outcome in HCV-HIV Coinfection

> FDA Safety Changes: Baraclude

> Genelabs Technologies Announces Presentation of Data on Non-Nucleoside HCV

Polymerase Inhibitor at the 15th International Symposium on Hepatitis C Virus

and Related Viruses

> Longing For A Liver

> Alcohol not only cause of cirrhosis

> Doctor blamed in case of infected IHC carer

> Viral Hepatitis C support group to begin meeting

> Ailing deputy withdraws grievance after county approves leave, insurance

> Cancer common after liver transplantation

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Mon, 15 Dec 2008 16:32:23 -0500

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> ***HEPATITIS JOURNAL REVIEW: A Bi-Monthly Publication of the Hepatitis Support

Project

>

> December 15 , 2008

> Volume 5, Issue 12

>

> Liz HighleymanTo download pdf version click here

>

> In This Issue:

>

> Pegasys Maintenance in HALT-C

>

> HCV Treatment in Prisons

>

> Hepatitis B and C Coinfection

>

> HIV Treatment Interruption

>

>

>

> ***Pushing Your Social Security Claim through the System

> Jacques Chambers, CLU, Benefits Consultant

>

>

>

> ***Top 10 Downloads of the Month

>

>

>

> ***HCV Drug Pipleline: Updated December 8, 2008

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** Clinical Trials: Updated

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: December 13 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> New Television Campaign In Mandarin To Educate Chinese Americans About Chronic

Hepatitis B

> Ask the Mayo Clinic: Whatever happened to 'jet injectors?'

> EU looks at increasing supply of transplant organs

> Human Genome Sciences Announces Albuferon® Meets Primary Endpoint in Phase 3

Trial in Chronic Hepatitis C

> Nuts boost health benefit of Mediterranean diet

> Atazanavir-treated patients have increased risk of hyperbilirubinaemia after

starting therapy for hepatitis C

> Leeds research points to new therapy for hepatitis C treatment

> Dementia risk not high in mild cognitive impairment

> Protecting Organ Recipients - From Donors

> Hepatitis C Deaths: Legacy Of Our Past Behaviour

> New pathway found for fatty liver disease

> 30-Day Hepatitis C Treatment Study Announced by Aethlon Medical

> Employed women with fibromyalgia maintain health

> Schering-Plough Announces FDA Approval of PEGINTRON and REBETOL®

Combination Therapy for Treating Pediatric Hepatitis C

> Sixth Annual Hepatitis C Summit

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Mon, 15 Dec 2008 16:32:23 -0500

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> ***HEPATITIS JOURNAL REVIEW: A Bi-Monthly Publication of the Hepatitis Support

Project

>

> December 15 , 2008

> Volume 5, Issue 12

>

> Liz HighleymanTo download pdf version click here

>

> In This Issue:

>

> Pegasys Maintenance in HALT-C

>

> HCV Treatment in Prisons

>

> Hepatitis B and C Coinfection

>

> HIV Treatment Interruption

>

>

>

> ***Pushing Your Social Security Claim through the System

> Jacques Chambers, CLU, Benefits Consultant

>

>

>

> ***Top 10 Downloads of the Month

>

>

>

> ***HCV Drug Pipleline: Updated December 8, 2008

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** Clinical Trials: Updated

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: December 13 , 2008

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> New Television Campaign In Mandarin To Educate Chinese Americans About Chronic

Hepatitis B

> Ask the Mayo Clinic: Whatever happened to 'jet injectors?'

> EU looks at increasing supply of transplant organs

> Human Genome Sciences Announces Albuferon® Meets Primary Endpoint in Phase 3

Trial in Chronic Hepatitis C

> Nuts boost health benefit of Mediterranean diet

> Atazanavir-treated patients have increased risk of hyperbilirubinaemia after

starting therapy for hepatitis C

> Leeds research points to new therapy for hepatitis C treatment

> Dementia risk not high in mild cognitive impairment

> Protecting Organ Recipients - From Donors

> Hepatitis C Deaths: Legacy Of Our Past Behaviour

> New pathway found for fatty liver disease

> 30-Day Hepatitis C Treatment Study Announced by Aethlon Medical

> Employed women with fibromyalgia maintain health

> Schering-Plough Announces FDA Approval of PEGINTRON and REBETOL®

Combination Therapy for Treating Pediatric Hepatitis C

> Sixth Annual Hepatitis C Summit

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Thu, 15 Jan 2009 18:44:00 -0500

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** January 2009 Hepatitis Journal Review Volume 6, Issue 1

> by Liz Highleyman

> Download English printable version

> In This Issue:

>

> STAT-C Resistance

>

> Liver Disease with Undetectable HCV RNA

>

> Effect of Diet in People with HCV

>

> Effects of Alcohol

>

> Mother-to-Child HCV Transmission

>

> Liver Transplant Allocation

>

>

> *** New Posters

> Poster are available as pdf's in both 8 1/2 x 11 and 11 x 17 format. You can

print out the smaller ones at home, while the 11 x 17 poster can be printed out

at a copy centre for less than $10

>

>

>

> *** Updated and Redesigned - HCV Treatment: A Guide to Help You Stay on

Treatment

>

>

>

> *** The Top Ten Downloads of the Month

> See what everyone is reading

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: January 10 , 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> Naomi Judd Celebrates " Miracles "

> Life And Death - The Program: Cumberland County's Treatment Court

> Treating Cystic Acne in Patients With Comorbid Conditions

> Hepatitis A vaccine gives long-lasting protection

> U.S. health spending hits $2.2 trillion in 2007

> Maternal Neutralizing Antibodies Don't Prevent Hepatitis C Virus Transmission

to Infants

> Failures to Follow Infection Practices Have Placed More than 60,000 Patients

at Risk for Hepatitis B and C

> Development of hepatocellular carcinoma in a patient 13 years after sustained

virological response to interferon against chronic hepatitis C: a case report

> Judge issues Hep C probe deadline

> A Dose of Reality

> ELAD® Liver Support System Study Initiated at Multiple U.S. Centers

> ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in

HCV-Infected Patients

> Get tested now, says hepatitis C survivor

> First Candidate from SCYNEXIS Novel Cyclophilin Inhibitor Platform, SCY-635,

Establishes Proof of Concept in HCV-Infected Adults

> Health group says local hepatitis C rate 'alarming' in at-risk residents

> A year later, hepatitis outbreak's upshot

> Health insurance no bargain for unemployed: group

> ph Bolduc Jr., 56, activist and former firefighter

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> The staff of the Hepatitis C Support Project / HCV Advocate Web site would

like to take this opportunity to wish everyone a happy, healthy and prosperous

new year!

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Thu, 15 Jan 2009 18:44:00 -0500

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** January 2009 Hepatitis Journal Review Volume 6, Issue 1

> by Liz Highleyman

> Download English printable version

> In This Issue:

>

> STAT-C Resistance

>

> Liver Disease with Undetectable HCV RNA

>

> Effect of Diet in People with HCV

>

> Effects of Alcohol

>

> Mother-to-Child HCV Transmission

>

> Liver Transplant Allocation

>

>

> *** New Posters

> Poster are available as pdf's in both 8 1/2 x 11 and 11 x 17 format. You can

print out the smaller ones at home, while the 11 x 17 poster can be printed out

at a copy centre for less than $10

>

>

>

> *** Updated and Redesigned - HCV Treatment: A Guide to Help You Stay on

Treatment

>

>

>

> *** The Top Ten Downloads of the Month

> See what everyone is reading

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: January 10 , 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

> This Issue:

>

> Naomi Judd Celebrates " Miracles "

> Life And Death - The Program: Cumberland County's Treatment Court

> Treating Cystic Acne in Patients With Comorbid Conditions

> Hepatitis A vaccine gives long-lasting protection

> U.S. health spending hits $2.2 trillion in 2007

> Maternal Neutralizing Antibodies Don't Prevent Hepatitis C Virus Transmission

to Infants

> Failures to Follow Infection Practices Have Placed More than 60,000 Patients

at Risk for Hepatitis B and C

> Development of hepatocellular carcinoma in a patient 13 years after sustained

virological response to interferon against chronic hepatitis C: a case report

> Judge issues Hep C probe deadline

> A Dose of Reality

> ELAD® Liver Support System Study Initiated at Multiple U.S. Centers

> ANA598 Demonstrates Potent Antiviral Activity in an Early Clinical Study in

HCV-Infected Patients

> Get tested now, says hepatitis C survivor

> First Candidate from SCYNEXIS Novel Cyclophilin Inhibitor Platform, SCY-635,

Establishes Proof of Concept in HCV-Infected Adults

> Health group says local hepatitis C rate 'alarming' in at-risk residents

> A year later, hepatitis outbreak's upshot

> Health insurance no bargain for unemployed: group

> ph Bolduc Jr., 56, activist and former firefighter

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> The staff of the Hepatitis C Support Project / HCV Advocate Web site would

like to take this opportunity to wish everyone a happy, healthy and prosperous

new year!

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Thu, 22 Jan 2009 20:40:32 -0500

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis C Streaming Videos:

> The excellent videos below have been produced by the Massachusetts Department

of Public Health Viral Hepatitis Program and are available in English, Spanish,

and Portuguese.

> Living with Hepatitis C: English - A film about hepatitis C from the

Massachusetts Department of Public Health (Windows Media File)

>

> Living with Hepatitis C: Portuguese (Windows Media File)

>

> Vivir con Hepatitis C: Aprenda Más - Asegúrese (Living with Hepatitis C) -

Una película sobre la hepatitis C, por el Departamento de Salud Pública de

Massachussetts (Windows Media File)

>

>

> ***ACTION ALERT: Sign On Letter - Viral Hepatitis in Senate Economic Stimulus

Bill

>

>

>

> *** Updated and Redesigned - Next Steps: When Treatment Isn't Working, by

Lucinda Porter, RN

>

>

>

> *** Updated: HCSP Hepatitis C Facts Series - HCV Education and Support

>

> Be sure to check out all of the updated factsheets in this series HCV

Education and Support

> * How to Tell Children They Have Hepatitis

>

> * Finding a Hepatitis C Support Group

>

> * A Brief History of HCV

>

> * Hepatitis C: Disclosure

>

> * Dispelling Myths about HCV

>

> * Testing Positive for Antibodies to the Hepatitis C Virus

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> Date: Thu, 22 Jan 2009 20:40:32 -0500

> Subject: HCV Advocate Email Alert

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> CC:

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** Hepatitis C Streaming Videos:

> The excellent videos below have been produced by the Massachusetts Department

of Public Health Viral Hepatitis Program and are available in English, Spanish,

and Portuguese.

> Living with Hepatitis C: English - A film about hepatitis C from the

Massachusetts Department of Public Health (Windows Media File)

>

> Living with Hepatitis C: Portuguese (Windows Media File)

>

> Vivir con Hepatitis C: Aprenda Más - Asegúrese (Living with Hepatitis C) -

Una película sobre la hepatitis C, por el Departamento de Salud Pública de

Massachussetts (Windows Media File)

>

>

> ***ACTION ALERT: Sign On Letter - Viral Hepatitis in Senate Economic Stimulus

Bill

>

>

>

> *** Updated and Redesigned - Next Steps: When Treatment Isn't Working, by

Lucinda Porter, RN

>

>

>

> *** Updated: HCSP Hepatitis C Facts Series - HCV Education and Support

>

> Be sure to check out all of the updated factsheets in this series HCV

Education and Support

> * How to Tell Children They Have Hepatitis

>

> * Finding a Hepatitis C Support Group

>

> * A Brief History of HCV

>

> * Hepatitis C: Disclosure

>

> * Dispelling Myths about HCV

>

> * Testing Positive for Antibodies to the Hepatitis C Virus

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Sat, 7 Mar 2009 15:32:34 -0500

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org

>

>

>

> *** HCV Advocate Newsletter: March, 2009

>

>

> In This Issue:

>

> Retrovirus Conference Report on HIV/HCV Coinfection

> Liz Highleyman

>

> HCV SnapShots

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: HCV Treatment and Sexual Dysfunction

> Lucinda Porter, RN

>

> HCV Treatment after Liver Transplantation

> Alan Franciscus, Editor-in-Chief

>

> Medical Writers' Circle Re-Launch

>

>

>

> *** HCV Drug Pipeline: Updated March 3, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

> *** HBV Journal Review, March 2009, by Kukka

>

>

> *** Hepatitis Journal Review , February 2009, by Liz Highleyman

>

> In This Issue:

>

> Extended Treatment for Genotype 1b

>

> Hepatocellular Carcinoma Risk

>

> Biliary and Pancreatic Cancer

>

> HCV Diagnosis in Coinfected People

>

> Pegasys vs. PegIntron for Coinfected Patients

>

>

>

> *** Updated HBV Advocate Easy B Factsheets

>

>

>

> *** Social Security Continuing Disability Reviews, by Jacques Chambers, CLU

>

>

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: March 7, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

>

> How Inflammatory Disease Causes Fatigue

> Economic Recovery Payments Coming For People Who Receive Social Security And

SSI Benefits

> High hepatitis C viral load increases risk of death in HIV/HCV coinfected

patients

> FTC Clears ZymoGenetics-Bristol-Myers Deal For Hepatitis C Drug Development

> Study Showing Improved Virologic Response with Nitazoxanide in Chronic

Hepatitis C Published in Gastroenterology

> Q & A: could I catch hepatitis C?

> Vertex Pharmaceuticals Strengthens HCV Drug Development Portfolio, Adds Novel

Polymerase Inhibitors to Shape New Combinations with Telaprevir

> Combination therapy eases fibromyalgia symptoms

> Hep C highest on North Coast

> Call for EU action on hepatitis death toll

> RF Ablation Linked to Improved Liver Cancer Survival

> Rates of Liver Cancer are Rising, but Survival is Increasing

> Continuous antiretroviral therapy improves survival in HIV/hepatitis C

co-infected patients with liver cirrhosis

> Proteomics Prove Accurate In Identifying Liver Cancer

> Sick, seeking answers

> NYC dialysis center tied to 9 hepatitis C cases

> Results may determine fate of Human Genome Sciences

> Electrochemical solution to virus detection

> HBV Polymerase Resistance Mutations May Be Antagonistic

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Thu, 19 Mar 2009 15:43:07 -0400

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org

>

>

>

> *** HCV Drug Pipeline: Updated March 13, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

> *** Medical Writers' Circle: HBV in Chidren, by Philip Rosenthal, MD

>

> *** Help with COBRA Premiums, by Jacques Chambers, CLU

>

> *** Top Ten Downloads - March 19, 2009

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: March 14, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Artificial Liver Extends Lives

> Two transplants later, couple longs for home

> Merck to buy Schering-Plough for US$41.1-billion

> Human Genome hepatitis C drug disappoints, shares crash

> Infection control flaws found at most Nev. Clinics

> Scripps Research Team Identifies Key Molecules that Inhibit Viral

> Production

> 16 patients have hepatitis in Army needle scare

> IHC cleared after carer catches hepatitis

> Public health warning issued over Mississauga tattoo parlour

> Ethnic Differences Found for Fatty Liver Disease and Insulin Resistance

> Hepatitis C increased risk for immune thrombocytopenic purpura

> FDA Approves Expanded Indication for Peginterferon-Based Combination

> Therapy for Chronic HCV

> VA Denies Hepatitis Results

> Roche and Genentech Reach a Friendly Agreement to Combine the Two

> Organizations and Create a Leader in Healthcare Innovation

> Vertex Pharmaceuticals Closes on Acquisition of ViroChem Pharma

> Anadys CEO says in late-stage partnership discussions

> Doctor fears needle disease outbreak

>

>

>

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Wed, 22 Apr 2009 14:36:27 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** Action Alert

>

> SENATE ACTION ALERT: Increase Funding to the Division of Viral Hepatitis to

> a Total of $50 Million

>

> *** Media Release: LARGE SCALE AUSTRALIAN HEPATITIS C STUDY SHOWS NEED TO

> TREAT SOONER

>

>

>

> *** HCV Drug Pipeline: Updated April 21, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** Medical Writers' Circle: Overview of Treatment of Hepatitis B, by

> Frenette, MD and Gish, MD

>

>

>

> *** MORE New HBV Factsheet Series

>

> Hepatitis B Basics: Hepatitis B Antigen and Antibody Tests

>

> HBV Fact Series: HBV Benefits and Disability Issues: Getting Disability

> Benefits Under Social Security, by Jacques Chambers, CLU

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: April 18, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Editorial: Addiction Behind Bars

> Newark program trades clean needles with 600 addicts

> Vaccination fears over plan for Hepatitis B jabs for babies

> Legislation drafted for bloodwork uniformity: Hepatitis B link prompts

> action

> Cancelled jailhouse tattoo program lauded

> Liver donor comes through for ailing field lieutenant

> Can-Fite set for liver cancer treatment study

> Patients at Dakota Dunes, SD clinic tested for possible infection

> Do patients at risk for B-cell malignancy need antiviral treatment?

> Report: Stroke's effects hurt Desai in defense effort

> Formula for justice Chemist snags $45M settlement after blowing whistle on

> med company

> Miami VA tests find 7 cases of hepatitis C, 1 HIV

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Wed, 22 Apr 2009 14:36:27 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** Action Alert

>

> SENATE ACTION ALERT: Increase Funding to the Division of Viral Hepatitis to

> a Total of $50 Million

>

> *** Media Release: LARGE SCALE AUSTRALIAN HEPATITIS C STUDY SHOWS NEED TO

> TREAT SOONER

>

>

>

> *** HCV Drug Pipeline: Updated April 21, 2009

>

> Check out the latest in Hepatitis C Treatment and Drug Development

>

>

>

> *** Medical Writers' Circle: Overview of Treatment of Hepatitis B, by

> Frenette, MD and Gish, MD

>

>

>

> *** MORE New HBV Factsheet Series

>

> Hepatitis B Basics: Hepatitis B Antigen and Antibody Tests

>

> HBV Fact Series: HBV Benefits and Disability Issues: Getting Disability

> Benefits Under Social Security, by Jacques Chambers, CLU

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: April 18, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

>

> Editorial: Addiction Behind Bars

> Newark program trades clean needles with 600 addicts

> Vaccination fears over plan for Hepatitis B jabs for babies

> Legislation drafted for bloodwork uniformity: Hepatitis B link prompts

> action

> Cancelled jailhouse tattoo program lauded

> Liver donor comes through for ailing field lieutenant

> Can-Fite set for liver cancer treatment study

> Patients at Dakota Dunes, SD clinic tested for possible infection

> Do patients at risk for B-cell malignancy need antiviral treatment?

> Report: Stroke's effects hurt Desai in defense effort

> Formula for justice Chemist snags $45M settlement after blowing whistle on

> med company

> Miami VA tests find 7 cases of hepatitis C, 1 HIV

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Mon, 1 Jun 2009 13:21:50 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

> www.hbvadvocate.org.

>

>

>

> *** HCV Advocate Newsletter: June, 2009

>

> To download pdf version click here

>

> In This Issue:

>

> EASL 2009

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: What the Heck is Hepatotoxicity?

> Lucinda Porter, RN

>

> HIV/HCV Coinfection News from EASL

> Liz Highleyman

>

> Disability & Benefits: An Overview of Disability Insurance Coverage

> Jacques Chambers, CLU

>

>

>

> ***HBV Journal Review: June 2009, by Kukka

>

>

>

> ***Hepatitis Journal Review: May, 2009, by Liz Highleyman

> In This Issue:

>

> Ribavirin Prevents Relapse

>

> Telaprevir

>

> Sorafenib for Cirrhosis

>

> CD4 Recovery in Coinfected Patients

>

> Injection Drug Use

>

>

>

> *** Top 10 Hepatitis B Downloads of the Month Updated May 20, 2009

>

>

>

> *** Top 10 Hepatitis C Downloads of the Month Updated May 20, 2009

>

>

>

> *** Updated Schedule of HCSP Hepatitis C Training Workshops for 2009

> Take a look to find out if our very popular training workshops are coming

> to where you live

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: May 30, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Statins May Potentiate Inhibition of Hepatitis C Virus Replication

> A Potential Drug For Liver Carcinoma

> Correctional Facilities and Viral Hepatitis

> Government Responds To Archer Inquiry

> Antibody to hepatitis B core antigen as a screening test for occult

> hepatitis B virus infection in Egyptian chronic hepatitis C patients

> Look Back - Hepatitis B Awareness Month

> FDA Working Group Recommends Revising Acetaminophen Dosing, Labels

> New Device For Liver Cancer Cleared

> New treatment option for patients with chronic hepatitis C

> Some donor factors affect outcomes for HCV-positive liver transplant

> recipients

> Severe hepatitis patients to receive special state support

> Illinois Senate Supports Medical Marijuana Bill

> Environmental Pollution Increases Risk Of Liver Disease, Study Finds

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

> reply to this email. Questions and/or comments can be directed to

> alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Wed, 1 Jul 2009 14:21:59 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> ***HCV Advocate on Twitter

>

> Join the HCV Advocate on Twitter (www.twitter.com/hcvadvocate) to find out the

lastest updates posted to the HCV Advocate Web site, our traveling training

program and the latest in our advocacy efforts.

>

>

> ***July 2009 HCV Advocate

> Download English printable version

> --------

>

> In This Issue:

>

> Pregnancy Drug Categories

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: Hepatitis C and Metabolic Syndrome

> Lucinda Porter, RN

> FDA Takes Action on Acetaminophen

> Liz Highleyman

> Book Review - Healing Hepatitis

> Lucinda Porter, RN

> Consequences of Hepatitis C - Cost of a Baby boomer Epidemic of Liver Disease

> Alan Franciscus, Editor-in-Chief

>

>

> *** HBV Journal Review, July 2009, by Kukka

>

> ***HEPATITIS JOURNAL REVIEW:

> A Bi-Monthly Publication of the Hepatitis Support Project

>

> June 29 , 2009

> Volume 6, Issue 6

> Liz HighleymanTo download pdf version click here

>

> In This Issue:

>

> Retreatment of Nonresponders

>

> Racial Differences in Interferon Response

> Interferon-Signaling Genes

>

> Persistent HCV after SVR

>

> HCV Sexual Transmission

>

>

> ***SSA Survivors' Benefits, by Jacques Chambers, CLU, Benefits Consultant

> To download pdf version click here

> In addition to providing benefits to immediate relatives of workers insured

under Social Security while the worker is still alive, Social Security provides

benefits to a surviving spouse, ex-spouse, child, or parent of an insured

worker. This article describes survivors' benefits. Read more......

>

> *** Top 10 HCV Downloads of the Month (June 09)

> Las 10 descargas más frecuentes del mes

>

> *** Top 10 HBV Downloads of the Month (June 09)

>

>

>

> *** Updated Schedule of HCSP Hepatitis C Training Workshops for 2009

> Click Here

>

> Take a look to find out if our very popular training workshops are coming to

where you live

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: June 27, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Hepatitis C Virus Infection and the Risk of Coronary Disease

> What I need to know about Liver Transplantation

> Women with Hypothyroidism at Increased Risk of Liver Cancer

> Providers Often Fail to Inform Patients of Abnormal Test Result

> Health of young offenders is poor

> CDC Researchers Release Latest Hepatitis A, B, and C Statistics

> HBeAg-Positive Pregnant Women With HBV DNA Warrant Further Assessment to

Prevent Transmission to Infant: Presented at ICC

> Did Steve Jobs' money buy him a faster liver transplant?

> U.S. pursues crackdown on healthcare fraud

> Groups urge FDA to release info on rejected drugs

> Should you get tested for hepatitis C?

> Hepatitis C Cases on the Rise in Langlade County

> Insulin Resistance Among Chronic Hepatitis C

> Conatus Pharmaceuticals Initiates A Second Phase 2 Clinical Trial For The

Treatment Of Hepatitis

> OraSure says FDA seeks more study on hepatitis C test

> Hepatitis C warning for cocaine snorters

> Liver Lines

> Teenager Jazzy de Lisser's award-winning film about living with killer disease

hepatitis C

> Fury as heroin addicts get " one hit kits " from Boots

> Three-Year Data Support Peginterferon Alfa-2a for HBeAg-Negative Chronic

Hepatitis B

> HIV Coinfection Has Little Effect on Response to Chronic Hepatitis B Treatment

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information:

[Guest guest]

> From: " www.hcvadvocate.org " <root@...>

> <emailalert@...>

> Subject: HCV Advocate Email Alert

> Date: Wed, 1 Jul 2009 14:21:59 -0400

>

>

>

> Hello,

>

> The following items have been posted to www.hcvadvocate.org and

www.hbvadvocate.org.

>

>

>

> ***HCV Advocate on Twitter

>

> Join the HCV Advocate on Twitter (www.twitter.com/hcvadvocate) to find out the

lastest updates posted to the HCV Advocate Web site, our traveling training

program and the latest in our advocacy efforts.

>

>

> ***July 2009 HCV Advocate

> Download English printable version

> --------

>

> In This Issue:

>

> Pregnancy Drug Categories

> Alan Franciscus, Editor-in-Chief

>

> HealthWise: Hepatitis C and Metabolic Syndrome

> Lucinda Porter, RN

> FDA Takes Action on Acetaminophen

> Liz Highleyman

> Book Review - Healing Hepatitis

> Lucinda Porter, RN

> Consequences of Hepatitis C - Cost of a Baby boomer Epidemic of Liver Disease

> Alan Franciscus, Editor-in-Chief

>

>

> *** HBV Journal Review, July 2009, by Kukka

>

> ***HEPATITIS JOURNAL REVIEW:

> A Bi-Monthly Publication of the Hepatitis Support Project

>

> June 29 , 2009

> Volume 6, Issue 6

> Liz HighleymanTo download pdf version click here

>

> In This Issue:

>

> Retreatment of Nonresponders

>

> Racial Differences in Interferon Response

> Interferon-Signaling Genes

>

> Persistent HCV after SVR

>

> HCV Sexual Transmission

>

>

> ***SSA Survivors' Benefits, by Jacques Chambers, CLU, Benefits Consultant

> To download pdf version click here

> In addition to providing benefits to immediate relatives of workers insured

under Social Security while the worker is still alive, Social Security provides

benefits to a surviving spouse, ex-spouse, child, or parent of an insured

worker. This article describes survivors' benefits. Read more......

>

> *** Top 10 HCV Downloads of the Month (June 09)

> Las 10 descargas más frecuentes del mes

>

> *** Top 10 HBV Downloads of the Month (June 09)

>

>

>

> *** Updated Schedule of HCSP Hepatitis C Training Workshops for 2009

> Click Here

>

> Take a look to find out if our very popular training workshops are coming to

where you live

>

>

>

> *** HCV ADVOCATE WEEKLY NEWS REVIEW:

> A Review of HCV, HBV and HIV/HCV Coinfection Related News and Highlights

>

> Week Ending: June 27, 2009

>

> Alan Franciscus

> Editor-in-Chief

>

> To download pdf version click here

>

>

> This Issue:

>

> Hepatitis C Virus Infection and the Risk of Coronary Disease

> What I need to know about Liver Transplantation

> Women with Hypothyroidism at Increased Risk of Liver Cancer

> Providers Often Fail to Inform Patients of Abnormal Test Result

> Health of young offenders is poor

> CDC Researchers Release Latest Hepatitis A, B, and C Statistics

> HBeAg-Positive Pregnant Women With HBV DNA Warrant Further Assessment to

Prevent Transmission to Infant: Presented at ICC

> Did Steve Jobs' money buy him a faster liver transplant?

> U.S. pursues crackdown on healthcare fraud

> Groups urge FDA to release info on rejected drugs

> Should you get tested for hepatitis C?

> Hepatitis C Cases on the Rise in Langlade County

> Insulin Resistance Among Chronic Hepatitis C

> Conatus Pharmaceuticals Initiates A Second Phase 2 Clinical Trial For The

Treatment Of Hepatitis

> OraSure says FDA seeks more study on hepatitis C test

> Hepatitis C warning for cocaine snorters

> Liver Lines

> Teenager Jazzy de Lisser's award-winning film about living with killer disease

hepatitis C

> Fury as heroin addicts get " one hit kits " from Boots

> Three-Year Data Support Peginterferon Alfa-2a for HBeAg-Negative Chronic

Hepatitis B

> HIV Coinfection Has Little Effect on Response to Chronic Hepatitis B Treatment

>

> Thanks!

>

> Alan Franciscus

> Executive Director, Hepatitis C Support Project

> Editor-in-Chief, HCV Advocate

>

>

>

> **Questions and Comments: If you have questions or comments please do not

reply to this email. Questions and/or comments can be directed to

alanfranciscus@...

>

> **Unsubscribe Information: